Cash, cash equivalents, and investments totaled $1.4B as of December 31, compared to $558.6M as of December 31, 2023. This includes gross ...

Citizens JMP lowered the firm’s price target on Crinetics (CRNX) to $91 from $92 and keeps an Outperform rating on the shares. Crinetics is ...

(RTTNews) - Crinetics Pharmaceuticals, Inc. (CRNX) Monday announced the appointment of Tobin Schilke as chief financial officer, effective February 28, 2025. Schilke, with over 25 years of global ...